DrugPatentWatch Database Preview
Methylphenidate hydrochloride - Generic Drug Details
What are the generic drug sources for methylphenidate hydrochloride and what is the scope of methylphenidate hydrochloride patent protection?
Methylphenidate hydrochloride has three hundred and ten patent family members in thirty-six countries.
There are thirty-one drug master file entries for methylphenidate hydrochloride. Thirty-seven suppliers are listed for this compound. There are two tentative approvals for this compound.
Summary for methylphenidate hydrochloride
International Patents: | 310 |
US Patents: | 27 |
Tradenames: | 12 |
Applicants: | 32 |
NDAs: | 56 |
Drug Master File Entries: | 31 |
Suppliers / Packagers: | 37 |
Bulk Api Vendors: | 39 |
Clinical Trials: | 344 |
Patent Applications: | 3,814 |
Formulation / Manufacturing: | see details |
Drug Prices: | see low prices |
DailyMed Link: | methylphenidate hydrochloride at DailyMed |
Pharmacology for methylphenidate hydrochloride
Drug Class | Central Nervous System Stimulant |
Physiological Effect | Central Nervous System Stimulation |
Synonyms for methylphenidate hydrochloride
113-45-1 (Parent) |
2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester, hydrochloride |
2-Piperidineacetic acid, alpha-phenyl-, methyl ester, hydrochloride |
2-Piperidineacetic acid, alpha-phenyl-, methyl ester, hydrochloride, (R*,R*)-(+-)- |
298-59-9 |
298M599 |
AC1L1SQ4 |
AC1Q5YRN |
AK116471 |
AKOS016010356 |
alpha-phenyl-2-piperidineacetic acid methyl ester hydrochloride |
AN-23356 |
API0003340 |
CAS-298-59-9 |
CC-30903 |
CCG-213572 |
CCRIS 6258 |
Centedrin |
Centedrine |
CHEBI:31836 |
CHEMBL1722 |
ciba 4311b |
Concerta (TN) |
CS-4658 |
D-erythro-Methylphenidate Hydrochloride |
D01296 |
DSSTox_CID_886 |
DSSTox_GSID_20886 |
DSSTox_RID_75843 |
DTXSID8020886 |
EINECS 206-065-3 |
FT-0603372 |
FT-0672046 |
FT-0672047 |
H-Tic-OtBu.HCl |
HE332528 |
HY-B1091A |
JUMYIBMBTDDLNG-UHFFFAOYSA-N |
LS-42 |
Medikinet |
Meridil hydrochloride |
Metadate |
Metadate (TN) |
Metadate CD |
Metadate ER |
Methyl .alpha.-phenyl-2-piperidineacetate hydrochloride |
methyl 2-phenyl-2-(2-piperidyl)acetate hydrochloride |
METHYL 2-PHENYL-2-(PIPERIDIN-2-YL)ACETATE HCL |
Methyl 2-phenyl-2-(piperidin-2-yl)acetate hydrochloride |
methyl 2-phenyl-2-piperidin-2-ylacetate hydrochloride |
methyl alpha-phenyl-2-piperidine-acetate hydrochloride |
Methyl alpha-phenyl-2-piperidineacetate hydrochloride |
Methyl Phenidylacetate Hydrochloride |
methyl phenyl(piperidin-2-yl)acetate hydrochloride |
Methylin ER |
Methylphenidan Hydrochloride |
Methylphenidate (hydrochloride) |
Methylphenidate HCl |
Methylphenidate hydrochloride (JAN/USP) |
Methylphenidate hydrochloride [USAN:JAN] |
Methylphenidate hydrochloride [USP:JAN] |
Methylphenidate Hydrochloride ER |
Methylphenidate hydrochloride solution, (Racemic mixture), ampule of 1 mL, 1.0 mg/mL in methanol (as free base), certified reference material |
Methylphenidate hydrochloride, European Pharmacopoeia (EP) Reference Standard |
METHYLPHENIDATE HYDROCHLORIDE(SEE ALSO: METHYLPHENIDATE, CAS 113-45-1, NTPNO M20344) |
Methylphenidate.HCl |
Methylphenidate(Ritalin) |
Methylphenidylacetate hydrochloride |
Metilfenidat hydrochloride |
MFCD00058191 |
MLS003922100 |
NCGC00091942-01 |
NCGC00257863-01 |
NSC 169868 |
NSC-169868 |
NSC-759278 |
NSC169868 |
NSC759278 |
Pharmakon1600-01505907 |
QuilliChew ER |
Quillivant XR |
Quillivant xr (TN) |
Rilaline |
Rilatine |
Ritalin |
Ritalin (TN) |
Ritalin hy drochloride |
Ritalin hydrochloride |
Ritalin LA |
Ritalin SR |
Ritalin-SR |
SC-83308 |
SCHEMBL41067 |
SMR000058998 |
threo-Methyl |A-phenyl-|A-(2-piperidyl)acetate hydrochloride |
Tox21_111186 |
Tox21_200309 |
TRANSGENIC MODEL EVALUATION (METHYLPHENIDATE HYDROCHLORIDE) (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE) |
WLN: T6MTJ BYR & VO1 & GH |
Tentative approvals for METHYLPHENIDATE HYDROCHLORIDE
Applicant | Application No. | Strength | Dosage Form |
➤ Try a Free Trial | ➤ Try a Free Trial | 10MG | CAPSULE, EXTENDED RELEASE; ORAL |
➤ Try a Free Trial | ➤ Try a Free Trial | 60MG | CAPSULE, EXTENDED RELEASE;ORAL |
➤ Try a Free Trial | ➤ Try a Free Trial | 50MG | CAPSULE, EXTENDED RELEASE;ORAL |
US Patents and Regulatory Information for methylphenidate hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kremers Urban Pharms | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 091695-004 | Sep 23, 2013 | BX | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
Janssen Pharms | CONCERTA | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021121-004 | Apr 1, 2002 | AB | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
Rhodes Pharms | APTENSIO XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 205831-001 | Apr 17, 2015 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
Rhodes Pharms | APTENSIO XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 205831-005 | Apr 17, 2015 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for methylphenidate hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-004 | Apr 10, 2004 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Novartis | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-001 | Jun 5, 2002 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Janssen Pharms | CONCERTA | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021121-001 | Aug 1, 2000 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Janssen Pharms | CONCERTA | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021121-003 | Dec 8, 2000 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Non-Orange Book US Patents for methylphenidate hydrochloride
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
9,675,704 | Modified release formulations containing drug-ion exchange resin complexes | ➤ Try a Free Trial |
8,597,684 | Modified release formulations containing drug-ion exchange resin complexes | ➤ Try a Free Trial |
6,673,367 | Controlled/modified release oral methylphenidate formulations | ➤ Try a Free Trial |
8,119,163 | Nanoparticulate and controlled release compositions comprising cefditoren | ➤ Try a Free Trial |
Patent No. | Title | Estimated Patent Expiration |
International Patents for methylphenidate hydrochloride
Country | Document Number | Estimated Expiration |
---|---|---|
Portugal | 1140088 | ➤ Try a Free Trial |
World Intellectual Property Organization (WIPO) | 2007027273 | ➤ Try a Free Trial |
Australia | 2006285349 | ➤ Try a Free Trial |
Canada | 2660649 | ➤ Try a Free Trial |
Country | Document Number | Estimated Expiration |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:









Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.